Shows
OncLive® On AirCollaborative Structural Reforms Represent a Way Forward for Oncology Innovations: With Elizabeth Mittendorf, MD, PhD, MHCMIn today’s episode, we sat down for part 2 of our discussion with Elizabeth Mittendorf, MD, PhD, MHCM, the 2026-2027 president-elect of the American Society of Clinical Oncology (ASCO). Dr Mittendorf holds numerous leadership roles, including the Robert and Karen Hale Distinguished Chair in Surgical Oncology and vice chair for research in the Department of Surgery at Brigham and Women's Hospital; co-leader of the Breast Program and director of the Breast Immuno-Oncology Program at the Dana-Farber Brigham Cancer Center; co-leader of the Parker Institute for Cancer Immunotherapy at the Dana-Farber Cancer Institute; and a professor of surgery at Harvard Medical Sc...2025-06-1009 minOncLive® On AirMultidisciplinary Collaboration and Mentorship Lay the Foundation for a New Chapter of ASCO Leadership: With Elizabeth Mittendorf, MD, PhD, MHCMIn today’s episode, we had the pleasure of speaking with Elizabeth Mittendorf, MD, PhD, MHCM, the 2026 president-elect of ASCO. Dr Mittendorf is the Robert and Karen Hale Distinguished Chair in Surgical Oncology and the vice chair for research in the Department of Surgery at the Brigham and Women's Hospital; co-leader of the Breast Program and director of the Breast Immuno-Oncology Program at the Dana-Farber Brigham Cancer Center; co-leader of the Parker Institute for Cancer Immunotherapy at the Dana-Farber Cancer Institute; and a professor of surgery at Harvard Medical School, all in Boston, Massachusetts.
In our exclusive interview, Dr...2025-06-0312 min
ASTRO JournalsRed Journal Podcast: Cover Art at the Red JournalSend us a textEditor in Chief Sue Yom hosts four of our artists – Jen Bellon, our journal’s Art Editor, who was previously at Dana Farber Cancer Institute/Brigham & Women’s Hospital, and now works as an independent art consultant; Annie Lavigne, Assistant Professor of Radiation Oncology at Johns Hopkins University; Josh No, Attending Physician at Kaiser Permanente; and Tony Orlina, Lead Dosimetrist at Dana Farber Cancer Center. They discuss the role of art in their lives, stories of their Red Journal cover artworks, and what they see as the role of art in medicine.2025-05-2347 min
BornCuriousStorytelling and Grief in Palliative CareThere is a long-held belief in the medical field that doctors should maintain a professional distance from their patients. But it’s only human to be affected by one’s everyday experiences—and for professionals who work with serious illness, these experiences can range from distressing to profound. In this episode, a collaboration with Grief Is a Sneaky Bitch, we discover how the Palliative Story Exchange uses storytelling to center human connection and meaning in this setting.
Released on May 22, 2025.
Episode Transcript
Guest Host
Lisa Keefauver is a social worker, a grief ac...2025-05-2252 min
Audio Journal of Oncology PodcastAdding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck CancersInterviews with:
Ravindra Uppaluri, MD PhD, Director of Head and Neck Surgical Oncology, Dana Farber Brigham Cancer Center, Boston MA;
And: Ryan B Corcoran MD PhD, Director of the gastrointestinal cancer program, Massachusetts General Hospital Cancer Center, Associate Professor of Medicine Harvard Medical School and Co-Chair of the American Association for Cancer Research Clinical Trials Committee.
CHICAGO, USA—Perioperative immunotherapy, using the PD-1 blocker pembrolizumab both before and after surgery, has been investigated in patients with newly diagnosed head and neck cancers in the phase three KEYNOTE-689 study. Findings were reported at the 2025 An...2025-05-0113 min
Patient from HellThe Rise of Young-Onset Colorectal Cancer: Environmental Factors and Screening StrategiesIn this episode, Dr. Tejas Jayakrishnan discusses the rising incidence of young onset colorectal cancer (CRC) and the potential environmental factors contributing to this trend. The conversation delves into the importance of screening protocols, the challenges faced in early detection, and the role of education in increasing awareness and understanding of cancer risks. Dr. Jayakrishnan emphasizes the need for tailored approaches in patient care, particularly for younger patients, and highlights ongoing research efforts aimed at improving outcomes in this demographic.About Our Guest:Dr. Thejus Jayakrishnan is a gastrointestinal medical oncologist at Dana-Farber Cancer Institute...2025-04-2343 min
ASTRO JournalsRed Journal Podcast: Cover Art at the Red JournalEditor in Chief Sue Yom hosts four of our artists – Jen Bellon, our journal’s Art Editor, who was previously at Dana Farber Cancer Institute/Brigham & Women’s Hospital, and now works as an independent art consultant; Annie Lavigne, Assistant Professor of Radiation Oncology at Johns Hopkins University; Josh No, Attending Physician at Kaiser Permanente; and Tony Orlina, Lead Dosimetrist at Dana Farber Cancer Center. They discuss the role of art in their lives, stories of their Red Journal cover artworks, and what they see as the role of art in medicine.2025-04-2247 min
OncLive® On AirStrong Mentorship Opportunities Support the Next Generations of Women in Lymphoma: With Chandler Park, MD; and Ann S. LaCasce, MD, MMScIn this week's episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, spoke with Ann S. LaCasce, MD, MMSc, an associate professor of medicine and a lymphoma specialist at Dana-Farber Cancer Institute in Boston, Massachusetts and Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. LaCasce shares her journey into hematologic oncology, shaped by early mentors—including her father—and how a passion for art history sparked her interest in pattern recognition and morphology, which are skills central to lymphoma diagnosis.
Their discussion explores key adva...2025-03-2620 min
SurgOnc Today®WICS Finance Series: Episode 4 - Organizational Fund FlowListen to the final episode of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Dr. Melissa Hogg, a member of the Women in Cancer Surgery Committee, and Dr. Tari King, Chief of Breast Surgery at Dana-Farber Brigham Cancer Center discuss organizational fund flow and share insights on managing financial matters in the field.2025-03-1926 min
Ribbit RibbitAI on the Air: Mar 03's Fresh Picks from ArXivToday's AI scoop: 326 new papers on ArXiv with 72 key highlights. For more details, visit https://ribbitribbit.co/podcast00:28 - arxiv:2502.21244 Northeastern University, Brigham and Women’s Hospital, Dana-Farber Cancer Institute...00:54 - arxiv:2502.21245 Tsinghua University01:16 - arxiv:2502.20966 University of Cambridge, Siemens AG, University of Oxford01:40 - arxiv:2502.21106 Siemens Healthineers, New York University, University of Maryland Medical Center...02:08 - arxiv:2502.21123 CISPA Helmholtz Center for Information Security, Max Planck Institute, ETH Zurich...02:33 - arxiv:2502.20490 University of Arizona, Stanford University, University of Toronto...02:55 - arxiv:2502.20770 California Institute of Technology, Un...2025-03-0429 min
Marrow MastersNurse Practitioner Lisa Stewart Shares Her Extensive Experience with GVHDIn this episode, we sit down with Lisa Stewart, a nurse practitioner with more than 25 years of transplant nursing experience, currently working at the post-transplant BMT clinic at the Dana-Farber Brigham Cancer Center in Boston. Lisa provides invaluable insights into managing chronic and acute graft-versus-host disease (GVHD) and shares her expertise, stories, and advice for patients and caregivers navigating post-transplant life.Lisa describes her role in outpatient care, where the majority of her work focuses on managing chronic GVHD, a condition that is both a sign of a functioning immune system and a complex challenge. While mild...2025-01-3018 min
WEEI/NESN Jimmy Fund Radio-TelethonPhaedra Ferrini, 24, metastatic paraganglioma, Boston, with Kimberly Perez , MD, Co-Director of Dana-Farber Cancer Institute Gastrointestinal Clinical Trials Program, Senior Physician, Dana-Farber, and Assistant Professor of Medicine at Harvard Medical ScPhaedra was 14 years old and sitting in her high school nurse’s office. The nurse noticed her pupils were dilated different sizes and called Phaedra’s mom, recommending she get checked out by a doctor. At the hospital, it was discovered that they had a benign tumor, which was promptly resected. Scans a few years later at 17 indicated that there were no signs of the cancer coming back. Dr. Kimberly Perez, MD is a member of the Dana-Farber Cancer Institute/Harvard Cancer Center Gastrointestinal Oncology and Cancer Genetics and Prevention disease centers. She is a Senior Physician in Me...2024-08-1409 min
WEEI/NESN Jimmy Fund Radio-TelethonCraig Bunnell, MD, Chief Medical Officer, Dana-Farber Craig Bunnell, MD, MPH, MBA, is the Morse Family Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hospital. In this role, Dr. Bunnell oversees adult and pediatric clinical services at Dana-Farber. Under his leadership, the Institute has become a leader in implementing technology to enhance patient flow, operational efficiency, and patient access. Dr. Bunnell is also a breast medical oncologist at Dana-Farber and an Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on...2024-08-1410 min
WEEI/NESN Jimmy Fund Radio-TelethonBarbara Ackerman, 72, lung cancer, Plymouth, with Pasi Jänne, MD, PhD, Senior Vice President for Translational Medicine, Dana-Farber Dr. Jänne received his MD and PhD from the University of Pennsylvania in 1996. He completed postgraduate training in internal medicine at Brigham and Women's Hospital and in medical oncology at DFCI in 2001. He is the Senior Vice President for Translational Medicine and the Scientific Director of the Belfer Center for Applied Cancer Science. His main research interests include studying the therapeutic relevance of oncogenic alterations in lung cancer. He was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations and has led the development of therapeutic strategies for patients with EGFR mutant lung cancer. In...2024-08-1410 min
WEEI/NESN Jimmy Fund Radio-TelethonJoel Davidson, 79, prostate cancer, Naples, FL, with Mark Pomerantz, MD, Clinical Director for the Lank Center for Genitourinary Oncology, Dana-FarberNine years ago, Joel was diagnosed with prostate cancer at his annual wellness exam while living in Connecticut; his best friend was his urologist at the time. He began making regular visits to Boston to get treated at Dana-Farber. Dr. Mark Pomerantz is a medical oncologist and Clinical Director for the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute. Dr. Pomerantz received his undergraduate degree from Yale University and his medical degree from Stanford University. He trained in Internal Medicine at Brigham and Women's Hospital in Boston, Massachusetts. He then pursued a fellowship in Medical Oncology...2024-08-1408 min
WEEI/NESN Jimmy Fund Radio-TelethonJaimey Buckley, 63, chronic lymphocytic leukemia, Middleboro, with Matthew Davids, MD, Dana-FarberJaimey was diagnosed with prostate cancer in 2008. He was treated and received a clean bill of health and remained cancer-free. In May 2015, a routine blood donation led to a life-changing discovery when the Red Cross director urged him to seek immediate medical attention. Jaimey was diagnosed with chronic lymphocytic leukemia (CLL), which, contrary to its typical slow progression, advanced rapidly in his case. Jaimey remained active, cycling and running to maintain his mental well-being.However, six to nine months ago, his CLL numbers began to rise again, promptingdiscussions about future treatments. Although his white...2024-08-1308 min
WEEI/NESN Jimmy Fund Radio-TelethonTina Kennedy, 34, breast cancer, Holbrook, with Erica Mayer, MD, Assistant Professor in Medicine at Harvard Medical School, Dana-FarberTina was 33 when she was diagnosed with breast cancer. She discovered a bumpnear her clavicle and went to her OGBYN who promptly sent her for a mammogram.Tina is among a growing number of young women being diagnosed with breast cancer. Tina’s treatment started with six rounds of chemotherapy, followed by a double mastectomy earlier this summer. She is currently doing some rounds of low dosage chemotherapy throughout the rest of this year and recently started radiation treatment as well. Tina works as a Government Relations Manager and works in public policy for2024-08-1310 min
WEEI/NESN Jimmy Fund Radio-TelethonRob Hale joins and says he'll match donations if we raise $775,000!!!Robert Hale, Donor Rob currently serves on Copley’s investment committee and as an entrepreneur in residence assisting the development of Copley’s portfolio companies. Rob founded Granite Telecommunications in 2002 and has grown the company into one of the largest privately held telecommunications services companies in the U.S., with revenues exceeding $1.5 billion. Rob is the founder and board chair of Fox Rock Capital, a single-family office based in Boston, founding owner of FoxRock Properties, a commercial real estate firm, and is co-owner of the NBA’s Boston Celtics and Boston Cannons of the Premier Lacrosse League. Rob lives in the Bo...2024-08-1308 min
Breastcancer.org PodcastPodcasting From the Chemo ChairCarly Fauth was diagnosed with breast cancer in January 2024. Scheduled to start chemotherapy in May, Carly decided to start a podcast called Chemo Coffee Talk, which she records from her chemo chair during her twice-monthly infusions at the Dana-Farber Brigham Cancer Center.Listen to the episode to hear Carly discuss:
how recording the podcast takes her mind off chemotherapy
how she selects her guests
what she plans to do with the podcast when her chemotherapy regimen ends
2024-08-0921 min
OncotargetImpact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast CancerBreast cancer immunotherapy has shown promise, but its clinical efficacy remains limited, especially for hormone receptor positive (HR+)/HER2-negative breast cancer. While immune checkpoint inhibitors combined with chemotherapy have benefitted some early-stage and metastatic triple-negative breast cancer patients, HR+/HER2-negative cases have seen fewer improvements.
Recent neoadjuvant trials indicate that early-stage HR+/HER2-negative breast cancers might respond better to immunotherapy strategies that amplify tumor-infiltrating lymphocytes (TILs) through dual PD-(L)1/CTLA-4 checkpoint inhibition before surgery and chemotherapy. This approach could enhance the immune response in the tumor microenvironment and improve outcomes for this challenging breast cancer subtype.
...2024-06-2008 min
All Things Cardio-OncologyChallenges of Starting a Cardio-Oncology Clinic: Dr. Anju NohriaDr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Assistant Professor of Medicine at Harvard Medical School (HMS).
On this episode she discusses the challenges and opportunities of starting a new clinic focused on cardio-oncology care.2024-05-2918 min
OncotargetDurvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast CancerBUFFALO, NY- March 27, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on March 19, 2024, entitled, “Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer.”
In this new study, researchers Haven R. Garber, Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Clinton Yam, Lumarie Santiago, Beatriz E. Adrada, Padmanee Sharma, Elizabeth A. Mittendorf, and Jennifer K. Litton from the University of Texas MD Anderson Cancer Center, Brigham and Women’s Hospital, Dana-Farber Brigham Cancer Center, and Harvard Medical School conducted a clinical trial to assess the feasibility of enrolling patients w...2024-03-2703 min
Continuum AudioSpinal Cord Neoplasms with Dr. J. Ricardo McFaline-Figueroa Tumors affecting the spine are fortunately uncommon, and may arise within the spine or metastasize from malignancies elsewhere. Effective treatment is determined by tumor type, location, and urgency. In this episode, Allison Weathers, MD, FAAN, speaks with J. Ricardo McFaline-Figueroa, MD, PhD, author of the article “Spinal Cord Neoplasms,” in the Continuum February 2024 Spinal Cord Disorders issue. Dr. Weathers is a Continuum® Audio interviewer and the associate chief medical information officer at Cleveland Clinic in Cleveland, Ohio. Dr. McFaline-Figueroa is a physician at Dana-Farber Cancer Institute and instructor in neurology at Brigham and Women...2024-02-2819 min
Canadian Urological Association (CUA)Canadian Expert discussion on optimizing RCC treatmentEpisode NotesPodcast Host Disclosures:Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan, Novartis, Oncohost, Pfizer, Roche, Sanofi/Aventis, Scholar Rock, Surface Oncology, Takeda, Tempest, Up-To-Date, CME events (Peerview, OncLive, MJH, CCO and others), outside the submitted work. Institutional patents filed on molecular alterations and immunotherapy response/toxicity, and ctDNA. Equity: Tempest, Pionyr, Osel, Precede Bio, CureResponse...2023-11-2942 min
Biotech 2050 PodcastNext-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime MedicineSynopsis:
Keith Gottesdiener, MD, and Jeremy Duffield, MD, PhD, FRCP, are the President & CEO and CSO, respectively, of Prime Medicine. Prime Medicine was founded to bring the promise of gene editing to patients. They use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Keith and Jeremy discuss the arc of their careers and how they go to where they are today. They talk about the differences working in big pharma vs. a smaller biotech like Prime. They discuss the importance of companies investing in safety and what they’ve lea...2023-11-2240 min
NETWiseNETWise Episode 29: Merkel Cell Carcinoma
One of the things that sets neuroendocrine tumors apart from other kinds of cancer is that they can occur almost anywhere in the body. Those different locations — or primary sites — can mean the NET takes on different characteristics, and requires different kinds of treatment. In previous episodes of this show, we’ve talked about lung NETs, pancreatic NETs, small bowel NETs, and gynecological NETs. Today, we’re going to be talking about skin NETs. These are known as Merkel cell carcinomas. Merkel cell carcinoma can be challenging to diagnose and treat, making early detection and medical attention crucial...2023-10-2043 min
ASCO EducationCancer Topics - Oncology Practice in Low-Resource SettingsResources such as facilities, equipment, medications, and trained healthcare professionals are essential to provide proper care. Yet, many areas in the US and around the globe have challenges providing some of such resources. This ASCO Education podcast will explore oncology practice in low resource settings. Dr. Thierry Alcindor, a medical oncologist at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, Dr. Richard Ingram, a Medical Oncologist at Shenandoah Oncology in Winchester, Virginia, and Chair of the Appalachian Community Cancer Alliance and Dr. Sana Al Sukhun, an Adjunct Professor of Medical Oncology and Director of Oncology Practice a...2023-10-1139 min
CareTalk: Healthcare. Unfiltered.What Dana-Farber's Shakeup Means for Cancer CareSend us a textThe Dana-Farber Cancer Institute rocked the cancer world this month by dropping its long standing partner, Brigham and Women’s in favor of building a new cancer hospital with Beth Israel. What does it mean for patients, physicians and health care costs?Is this just a local Boston story or is there broader meaning for the US healthcare system?ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. He...2023-09-2919 min
Health & VeritasNita Ahuja: Epigenetics and CancerHowie and Harlan are joined by Nita Ahuja, a Yale surgeon and researcher, to discuss new methods in for detecting and treating cancers and the barriers faced by women surgeons. Harlan answers questions about an FDA panel’s finding that the decongestant phenylephrine is ineffective; Howie looks at the trends making hospital finances unsustainable. Links: “FDA clarifies results of recent advisory committee meeting on oral phenylephrine” “Phenylephrine vs. Pseudoephedrine: What’s the Difference?” “Why Has a Useless Cold Medication Been Allowed on Shelves for Years?” “Surgeon Sex and Long-Term Postoperative Outco...2023-09-2136 min
Being and DoingBeing and Doing with Dr. Daphne Haas-Kogan on Being the Light for Others - ep33"The potential to impact the world and benefit others and do good is so immense that competition is really undermining."
Daphne Haas-Kogan, MD is an American radiation oncologist. She received her medical degree from the University of California at San Francisco (UCSF) in 1991. She completed a research fellowship, followed by residency in radiation oncology at the UCSF. Dr. Haas-Kogan spent 18 years as a radiation oncologist, researcher, and academic leader in the UCSF HDFCCC system before becoming chair of the Department of Radiation Oncology at Dana-Farber, Brigham and Women’s Hospital, and Boston Children’s Hospital in 2015.
If you like what...2023-09-2143 min
The Answers for CancersRadiotherapy for Breast Cancer Patients with Dr Daniel CagneyThis week on the podcast we are joined by Dr Daniel Cagney to discuss Radiotherapy for Breast Cancer Patients .
Dr. Daniel Cagney is clinical director of radiation oncology at Mater Private Hospital, Dublin and network director of stereotactic radiation.
Dr. Cagney’s internship and general medical training was in the Mercy Hospital Cork and Beaumont Hospital, Dublin. He did a year in medical oncology in Mater Hospital before commencing specialist training in radiation oncology in St Luke’s Hospital, Dublin. In parallel to his radiation oncology training, he received a MSc in oncol...2023-09-1830 min
Speaking of SurgOncImpact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast CancerRick Greene, MD, and Tari King, MD, FSSO, discuss findings generated from central path review of a large series of patients treated with neoadjuvant chemotherapy and surgery regarding the pattern of residual tumor in the breast and its related prognostic significance. Dr. King is the senior author of, “Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer.” Dr. Tari A. King is the Anne E. Dyson Professor of Surgery at Harvard Medical School, the chief of the Division of Breast Surgery and the vice chair of mul...2023-09-1215 min
Lung Cancer ConsideredLive from WCLC: Monday HighlightsMonday at WCLC 2023 features the Presidential Symposium. In this special WCLC 2023 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu talk with Dr. Eric Lim about MARS 2: A Multicentre Randomized Trial Comparing (Extended) Pleurectomy Decortication versus No Radical Surgery for Mesothelioma. Dr. Paula Ugalde, discussant for MARS 2, provides her unique overview and perspective on research presented today. The hosts also talk with Dr. P.C. Yang about the new results presented in the TALENT study of lung cancer screening in Taiwan. Emi Bossio, a patient research advocate and board member of Lung Cancer Canada adds her...2023-09-1154 min
Health Professional Radio - PodcastGenmab and AbbVie Present New Epcoritamab Data at EHA 2023Dr. Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie's preliminary data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in patients across B-Cell lymphomas that were presented at the European Hematology Association's (EHA) Annual Meeting 2023. Read the abstract here.
#EPCORE
Dr. Merryman received his undergraduate degree from the University of Notre Dame and his medical degree from Harvard Medical School. He completed residency training in internal medicine at Brigham and Women's Hospital and fellowship training in hematology and oncology at Dana-Farber/Partners Cancer Car...2023-09-0707 min
WEEI/NESN Jimmy Fund Radio-TelethonMeghan Hesketh, 28, breast cancer, Boston, with Ann Partridge, MD, MPH, Founder and Director, Program for Young Adults with Breast CancerAfter difficulty breathing, Megan subsequently tested positive for COVID, which doctors initially thought was the cause of her symptoms. But her oxygen saturation, or the balance of oxygen in her blood, remained low, so she underwent additional testing. Then, a chest x-ray revealed two liters of fluid in her lungs. After a fusion biopsy, she was officially diagnosed with Stage 4 breast cancer in June of 2022. Since then, Megan has been treated with hormonal therapy and continues to receivetreatment today. She also has tremendous support from her family members, both of whom also work in the...2023-08-3007 min
WEEI/NESN Jimmy Fund Radio-TelethonBarry Nelson, 70, lung cancer, Boston, with Chris Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer, Faculty Director for Cancer Care Equity, Dana-FarberIn 2012, Barry noticed some swelling on his neck, so he made an appointment to see his primary care physician. An x-ray and CT scan lead to follow-up appointments with various specialists until he was diagnosed with Stage 3B non-small cell lung cancer. Barry was initially going to get treatment at another institution but stopped at Dana-Farber to get a second opinion from Dr. Lathan. He recalls Dr. Lathan telling him they’d use all the tools in the toolbox and fight as hard as he could. From there, Barry knew he was in the right place. The tr...2023-08-3010 min
WEEI/NESN Jimmy Fund Radio-TelethonDana Mohrlein, 35, astrocytoma, Niantic CT, with David Reardon, MD Clinical Director, Center of Neuro-Oncology, Dana-FarberDana Mohrlein, 35, astrocytoma, Niantic CT, with David Reardon, MD Clinical Director, Center of Neuro-Oncology, Dana-Farber In college, Dana thought she may have vertigo because of all her headaches, but after aseizure at her first security job, she learned she needed emergency brain surgery. After surgeryat her local hospital, she pursued a second opinion at Dana-Farber and has continued herjourney from there since. She had two additional brain surgeries that same summer atBrigham-Women's Hospital. Shortly after, she started high dose radiation locally, in partnershipwith Dana-Farber, and did 11 months...2023-08-3010 min
WEEI/NESN Jimmy Fund Radio-TelethonElle Simone Scott joins Joe & Will from the booth!As a cast member/chef on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women chefs of color seeking success in the food and beverage, media, and hospitality industries. Elle found a new doctor once she arrived in Boston, got another ultrasound, and learned she had a cyst with cancerous concerns on her right ovary. Her doctor...2023-08-3005 min
WEEI/NESN Jimmy Fund Radio-TelethonKeith Johnson, 68, stomach cancer, Brookline, with Ben Schlechter, MD, Senior Physician, Gastrointestinal Cancer, Dana-FarberAfter initially experiencing mild symptoms such as intolerance for spicy and acidic foods and abdomen soreness, Keith Johnson, a neurologist at Mass General Brigham, went to see his primary care physician when he noticed that these symptoms had worsened after a few months. He was diagnosed with stomach adenocarcinoma or stomach cancer in March 2021 and was started on a combination of chemotherapy and immunotherapy at Dana-Farber Cancer Institute under the care of his oncologist Dr. Ben Schlechter. Most cancers of the stomach (about 90% to 95%) are adenocarcinomas. These cancers develop from the gland cells in the innermost lining...2023-08-2906 min
WEEI/NESN Jimmy Fund Radio-TelethonMary Worthington Kachadurian, 65, follicular lymphoma, Boston, with Ann S. LaCasce, MD, MMSc, Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/OncologyBlood in her urine lead Mary to get a kidney stone scan, but incidentally revealed that she had lymphoma. She immediately called Dana-Farber and was connected with the Cancer Diagnostic Service at Dana-Farber Brigham Cancer Center, which was new at the time of her lymphoma finding in 2018. The staff there cared for and led her through an expedited process to an official diagnosis of follicular lymphoma. At the same time, Mary had been training for the 2018 Pan Mass Challenge. She started chemotherapy in the in the fall of 2018, every 3 weeks for 6 cycles, because the cancer had become...2023-08-2908 min
Johns Hopkins Kimmel Cancer Center PodcastsOn Target with Dr Akila Viswanathan - Palliative Care for Seminars in Radiation OncologyDr Akila Viswanathan and Dr Tracy Balboni from Harvard Medical School and Dana-Farber/Brigham and Women's Cancer Center discuss the latest developments in palliative care for Seminars in Radiation Oncology.2023-07-2523 minJohns Hopkins Kimmel Cancer CenterOn Target with Dr Akila Viswanathan - Palliative Care for Seminars in Radiation OncologyDr Akila Viswanathan and Dr Tracy Balboni from Harvard Medical School and Dana-Farber/Brigham and Women's Cancer Center discuss the latest developments in palliative care for Seminars in Radiation Oncology.2023-07-2523 min
Hopkins Biotech PodcastBoston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint TherapeuticsDr. Isaac Klein is the Chief Scientific Officer at Dewpoint Therapeutics. Dewpoint Therapeutics is leveraging condensate biology to impact a wide range of therapeutic targets across diverse disease areas. Armed with significant funding from venture capital and several big pharma partnerships, Dewpoint is poised to lead the generation of medicines targeting biomolecular condensates.Prior to joining Dewpoint, Isaac was on the faculty at the Dana Farber Cancer Institute and Harvard Medical School, as well as a scientist at the Whitehead Institute of MIT. He holds a Ph.D. in Biology...2023-07-1738 min
AUANews Inside TractVoices: FUTURE in Urology Recap #1Today’s podcast episode is part of the “Voices” series and is brought to you by the Diversity, Equity & Inclusion Committee. Dr. Quoc-Dien Trinh, associate professor of surgery at Harvard Medical School; chief of urology at Brigham and Women's Faulkner Hospital and co-director of the prostate cancer program at the Dana-Farber/Brigham and Women's Cancer Center, sits down with his mentee, Jameshisa Alexander, first year medical student at the Morehouse School of Medicine, to discuss the inaugural FUTURE in Urology Program held in conjunction with AUA's Annual Meeting in April 2023.2023-06-2717 min
The Medicine Mentors PodcastBuilding a Mentorship Mosaic with Dr. Ann LaCasceAnn LaCasce, MD, is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology and an Associate Professor of Medicine at Harvard Medical School. Dr. LaCasce completed her medical school from Tufts University and residency in Internal Medicine at Brigham and Women’s Hospital where she later served as Chief Medical Resident, followed by a fellowship in Hematology/Oncology at the Dana-Farber Cancer Institute. She is a nationally renowned lymphoma specialist, chairs the steering committee for Women in Lymphoma and is currently serving as Chair-elect of the Lymphoma Research Foundation. “You’re never going to find one person who can...2023-03-0820 min
Conversations in Lung Cancer ResearchCelebrating Female Leadership in Medical ResearchIn this TOGA Podcast, and on International Women’s Day 2023, we celebrate female leadership in medical research. We explore the challenges and success pathways across different career stages for women who work in medical oncology and clinical research. Associate Professor Prunella Blinman, head of the medical oncology department at Concord Hospital and past chair of the Medical Oncology Group of Australia, is joined by Assistant Professor Narjust Florez, Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center; Professor Lorraine Chantrill, medical oncologist and Head of Service for Medical Oncology across th...2023-03-0831 min
VJOncology PodcastKey data and hot topics in prostate cancer at ASCO GU 2023In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at the ASCO Genitourinary Cancers Symposium 2023, including TRITON3, CheckMate650, and FORMULA-509. We’ll also be hearing perspectives on some of the hot topics in the field, such as treatment sequencing and combination therapies, unanswered questions for the use of PSMA PET in the staging of disease, and the use of active surveillance in localized prostate cancer.
Join Alan Bryce, MD, Mayo Clinic, Rochester, MN, Russell Kent Pachynski, MD, Washington University School of Medicine, St. Louis, MO, Paul Nguy...2023-03-0320 min
VJOncology PodcastKey data and hot topics in prostate cancer at ASCO GU 2023In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at the ASCO Genitourinary Cancers Symposium 2023, including TRITON3, CheckMate650, and FORMULA-509. We’ll also be hearing perspectives on some of the hot topics in the field, such as treatment sequencing and combination therapies, unanswered questions for the use of PSMA PET in the staging of disease, and the use of active surveillance in localized prostate cancer.
Join Alan Bryce, MD, Mayo Clinic, Rochester, MN, Russell Kent Pachynski, MD, Washington University School of Medicine, St. Louis, MO, P...2023-03-0320 min
CLOT ConversationsDOACs vs VKAs in thrombotic APS - Dr Jean Connors & Dr Behnood BikdeliSend us a textIn this interview, two of the authors of the paper Direct oral anticoagulants vs vitamin-K antagonists in thrombotic antiphospholipid syndrome: meta-analysis of randomized controlled trials, Dr Jean Connors and Dr Benhood Bikdeli, provide listeners with an overview of their systematic review and meta-analysis that evaluated the efficacy and safety of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in patients with thrombotic antiphospholipid syndrome. The authors searched through three databases (PubMed, EMBASE, and Cochrane Central Register of Controlled Trials) and found four eligible randomized controlled trials with a total...2023-02-0320 min
CANCER BUZZEngaging Patients with Small Cell Lung Cancer in Clinical TrialsMany patients with SCLC have a high symptom burden, poor prognosis, adherence challenges due to treatment-related adverse events, stigmatization, and emotional distress. Clinical trials are taking place across the country for patients with all stages of small cell lung cancer. CANCER BUZZ spoke to David Waterhouse, MD, MPH, Medical Oncologist and Hematologist at the Dana-Farber Brigham Cancer Center, Milford Regional Medical Center in Milford, MA. Hear how to engage patients in clinical trials and address barriers. “Eighty-five percent (85%) of cancer care is being done in the community, not at academic centers such as ours. And so, you have t...2022-11-2209 min
Prostate Cancer AwareRadiation Oncology Teamwork with Dr. Peter OrioOn this episode host & prostate cancer survivor Jonathan Chance talks with Dr. Peter Orio who is the Vice Chair of Network Operations at the Dana-Farber | Brigham Cancer Center Department of Radiation Oncology about radiation oncology teamwork for the treatment of prostate cancer. Dr. Orio also discusses why men should not to ignore prostate cancer. Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about h...2022-11-1306 min
Causes or CuresEvidence for an Emerging Epidemic of Cancer in Young People, with Dr. Shuji OginoSend us a textIn this Causes or Cures episode, Dr. Eeks chats with Dr. Shuji Ogino about his recent paper published in Nature Reviews, Clinical Oncology, titled "Is early-onset cancer an emerging global epidemic? Current evidence and future implications." In the podcast, Dr. Ogino discusses what "early onset" means, what types of cancer are showing up earlier in people less than 50 years of age, and the evidence and data that supports this trend. He discusses how exposures early in life and in utero may be contributing to early-onset cancer in young people ( in their thirties...2022-11-0257 min
Research Round-upNovember 2022 - Assoc. Prof Dani Margalit & Dr Rebecca VenchiaruttiDr Kristi Milley speaks with Associate Professor Dani Margalit from Harvard Medical School. She specialises in Head and Neck Cancer Treatment and is also the Director of Radiation Oncology at the Dana-Farber/Brigham Merkel Cell Cancer Centre. We also welcome back Dr Rebecca Venchiarutti onto the podcast, a Head and Neck Research Fellow at Chris O'Brien Lifehouse and at the University of Sydney. Dani and Rebecca are part of a team that has published a new systematic review about interventions for head and neck cancer survivors in the journal Head and Neck.2022-10-3122 min
WEEI/NESN Jimmy Fund Radio-TelethonKhiem Tran, 34, rectal cancer with metastasis to liver, Watertown, with Dr. Doug Rubinson, PHD, gastrointestinal oncologist, Dana-Farber After visits to his local doctor and urgent care, it was believed that Kheim’s rectal bleeding and extra fatigue could be attributed to hemorrhoids. Instead, learning the news through a phone call, Kheim was diagnosed with rectal cancer with metastasis to liver at age 32 after receiving additional scans and examinations. Once at Dana-Farber, with the help of his oncologist, Dr. Douglas Rubinson, Kheim beganchemotherapy infusions, but his nurses noted that he always seemed a bit “off.” After his family found Kheim at home, nearly unresponsive, it was later discovered that a genetic quirk caused Kheim to metabolize the ch...2022-08-2308 min
WEEI/NESN Jimmy Fund Radio-TelethonDaniel Ramos, 40, acute myeloblastic leukemia, Attleboro, with daughter, Leia Ramos (8), wife, Katharine Ramos, sister, Lidia Thomas, and Dr. Richard Stone, Chief of Staff and Director, Translational Research, Adult Leukemia Program, Dana-Farber and his DDaniel Ramos, 40, acute myeloblastic leukemia, Attleboro, with daughter, Leia Ramos (8), wife, Katharine Ramos, sister, Lidia Thomas, and Dr. Richard Stone, Chief of Staff and Director, Translational Research, Adult Leukemia Program, Dana-Farber wit his doctor, Dr. Richard Stone ? Daniel had noticed his energy and endurance levels were very low and spoke to hisdoctor about it at his annual physical. Subsequent bloodwork showed very highwhite blood cell counts and he was told to go to the emergency room at Brighamand Women's as they were confident it was Leukemia. This took place at the...2022-08-2305 minProstate Cancer AwareRadiation therapy & Brachytherapy with Dr. Peter OrioOn this episode host Jonathan Chance talks with Dr. Peter Orio, who is the Vice Chair of Network Operations at the Dana-Farber | Brigham Cancer Center Department of Radiation Oncology. He is also the Director of Prostate Brachytherapy and an Associate Professor at the Harvard Medical School. Dr. Orio provides important information about the various forms of radiation therapy for the treatment of prostate cancer as well as what questions a patient should ask their doctor about radiation therapy. Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of th...2022-08-0711 minASCO EducationOncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1)In part one of a two-part conversation, Drs. Patrick Loehrer and David Johnson sit down with Dr. Deborah Schrag to discuss her roles as a leader, researcher, oncologist and public health expert. The current Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, Dr. Schrag discusses the joy and passion she has found throughout her career, and more. If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at education@asco.org. TRANSCRIPT Dr. Pat Loehrer: I'm Pat L...2022-05-0327 min
ChemisteaFrontline COVID-19 research, fitness, and a new chapter in an academic career: a Chat with Dr. Alana Ogata (University of Toronto)Dr. Alana Ogata, Ph.D. is an Assistant Professor jointly appointed in the Department of Chemistry and Department of Chemical and Physical Sciences at the University of Toronto Mississauga (UTM). Throughout her academic career, she has received seven fellowships and published 19 papers in high-impact journals, such as NanoLetters and JACS, providing important contributions to the fields of electrochemical biosensors, non-classical nucleation and growth, and disease diagnostics. As an NSF Graduate Research Fellow under Dr. Reg Penner at UC Irvine, she developed a new electrochemical biosensor named the virus bioresistor (VBR), capable of label-free and rapid protein detection for point-of-care...2021-09-031h 06
WEEI/NESN Jimmy Fund Radio-TelethonOMF - Jeff Kitaeff (71) discusses his fight with lung cancerJeff describes himself as "the luckiest person I know." The first year after his lung cancer diagnosis was difficult, with lots of medicine and oyxgen tanks. But thanks to Dana-Farber and Brigham and Women's, Jeff feels terrific today and hopes that feeling will last a long, long time He is currently on a clinical trial that requires regular visits to Dana-Farber every three weeks, a schedule he happily follows with a smile. Jeff calls every member of his care team “absolutely fantastic." On his treatment experience, Jeff says: "I truly believe that every doc and tech and sta...2021-08-2406 min
WEEI/NESN Jimmy Fund Radio-TelethonGresh & Keefe- Chris Devin joins the show to discuss his battle with multiple myelomaChris Devin was diagnosed with multiple myeloma at the age of 45 during the heart of the Covid-19 pandemic. Chris immediately underwent five straight days on intensive radiation that stopped his excruciating headaches and readied him for a clinical trial at Dana-Farber/ Brigham. Devin and his wife Erica have been transparent with their kids about their father's situation. 2021-08-2405 min
WEEI/NESN Jimmy Fund Radio-TelethonGHS- Caroline McGuirk and Dr. Filipa Lynce join the show to discuss Caroline's battle with inflammatory breast cancerCaroline McGuirk is an inflammatory breast cancer patient at Dana Farber. Caroline was experiencing some skin changes on her right breast beginning in September 2020. While it wasn't overly alarming, she thought she had an infection, which the Web told her often clears itself. She underwent 20 weeks of chemotherapy, followed by modified radical mastectomy and then 6 weeks of radiation. Dr Fliipa Lynce received her medical degree from the Universidada Nova de Lisboa, Portugal in 2004. In 2020 she joined the staff of Dana-Farber Caner Institute and Brigham Women's Hospital, where she is a medical oncologist and cl...2021-08-2407 min
ASCO GuidelinesManagement of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO GuidelineAn interview with Dr. Muriel Brackstone from London Health Sciences Centre and Dr. Tari King from Dana Farber and Brigham and Women’s Cancer Center, authors on “Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline.” This guideline addresses management & timing of surgical and radiotherapeutic treatment of the axilla in early breast cancer. Read the guideline at asco.org/breast-cancer-guidelines. Suggest a topic for guideline development at surveymonkey.com/r/ascoguidelinesurvey. TRANSCRIPT [MUSIC PLAYING] SPEAKER: The purpose of this podcast is to educate and to inform. This is not...2021-07-1913 min
Learn Skin with Dr. Raja and Dr. HadarEpisode 88: Podcasting in DermatologyReady to get a little meta? Dr. Vinod Nambudiri joins the podcast to discuss, you guessed it, podcasts. Tune in for a discussion on dermatology podcasts, CME accreditation, and some elements to consider next time you're invited as a guest. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Vinod Nambudiri, MD MBA is a dermatologist in Myrtle Beach, SC and has over 11 years of experience in the medical field. He graduated from Harvard Medical S...2021-06-1024 min
Real PinkHow Researcher Perseverance Prevails in the Face of ChallengesMany scientific researchers face challenges in their work and the Covid-19 pandemic has only added to these challenges, but researchers are incredibly resilient and continue to push forward because they know their work will help patients and improve lives. Today, we are talking to Dr. Jennifer Guerriero, Instructor in Medicine and the Director of the Breast Tumor Immunology Laboratory at the Brigham and Women’s Hospital Department of Surgery. Dr. Guerriero is a Komen-funded early career investigator and will talk about some of the challenges she has faced and what has motivated her to push through them.
Dr...2021-03-0819 min
Global Medical Office DialoguesNobel Prize Laureate, Dr. William Kaelin, Jr.We talk with celebrated physician-scientist and researcher, William Kaelin Jr., MD, Sydney Farber Professor at Harvard Medical School, Dana Farber and Brigham and Women's Hospital in the United States, and winner of the 2019 Nobel Prize for his research with two others regarding how cells sense and adapt to oxygen availability with implications for anemia and chronic kidney disease care. 2021-02-1025 min
Cancer Stories: The Art of OncologyConversations with the Pioneers of Oncology: Dr Hyman MussDr. Hayes interviews Dr. Muss on geriatric oncology. Dr. Daniel F. Hayes is the Stuart B. Padnos Professor of Breast Cancer Research at the University of Michigan Rogel Cancer Center. Dr. Hayes’ research interests are in the field of experimental therapeutics and cancer biomarkers, especially in breast cancer. He has served as chair of the SWOG Breast Cancer Translational Medicine Committee, and he was an inaugural member and chaired the American Society of Clinical Oncology (ASCO) Tumor Marker Guidelines Committee. Dr. Hayes served on the ASCO Board of Directors, and served a 3 year term as President of AS...2021-01-2235 min
Journal of Urology PodcastsEditor’s Pick: Health Services ResearchInterview with: Quoc-Dien Trinh, MD FACS, Co-Director, Dana-Farber/Brigham and Women's Prostate Cancer Program, Director, Ambulatory Clinical Operations, Division of Urological Surgery, Associate Professor of Surgery, Harvard Medical School, Boston, Massachusetts Interviewed by John W. Davis, MD, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Referenced articles: Meera R. Chappidi MR, Stimson CJ, Kates M et al: A nationally representative study of nonindex hospital readmissions following radical prostatectomy: implications for bundled payment models. J Urol 2020; 203: 546. https://doi.org/10.1097/JU.0000000000000522 Abello A, Leapman M...2020-11-1144 min
AAMDSIF Podcasts for PatientsAAMDSIF SERIES Podcast Episode 48: Dr David Steensma discusses MDS and toxinsDr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator. Dr. Steensma is an associate professor at Harvard Medical School and faculty member in the leukemia program at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, Massachusetts and the Edward P. Evans Chair in MDS at Dana-Farber Cancer Institute2020-05-1500 min
After the CrisisShowing Self-Love Through Healthy Lifestyle Choices with Stacy KennedyToday on After the Crisis, nutrition and fitness expert Stacy Kennedy reveals the three obstacles every person must overcome in order to maintain a healthy lifestyle. Listen in as Victoria and Stacy discuss weighing the cost of healthy food vs. fast food, how regular activity supports weight management, and why sleep is critical to gut health. Stacy is a board-certified specialist in oncology nutrition and an integrative nutritionist for Reboot with Joe. Stacy is featured in the award-winning documentary films, Fat, Sick & Nearly Dead and Fat, Sick & Nearly Dead 2, is a senior clinical nutritionist at the Dana-Farber/Brig...2020-03-1043 min
Understanding Cancer | Dana-Farber Cancer InstituteCancer Mythbusters: Pancreatic CancerWhat is the number one cause of pancreatic cancer? What are the early warning signs of this disease? And how are researchers making progress in the treatment of pancreatic cancer overall?
In this episode of Cancer Mythbusters from Dana-Farber Cancer Institute, we talk about some of the most common questions and myths about pancreatic cancer with Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber/Brigham and Women's Cancer Center.2020-03-0608 min
Essential WisdomAnn LaCasce, MD, MMSc - Hematology and OncologyHelp me welcome Dr. Ann LaCasce! Dr. LaCasce practices medical oncology at Dana Farber Cancer Institute in Boston, MA. She is the Director of Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship, an Associate Professor of Medicine at Harvard Medical School, and an Instructor of Medical Oncology at Dana-Farber Cancer Institute. Dr. LaCasce received her MD from Tufts University and went on to complete residency in Internal Medicine at Brigham and Women’s Hospital. She earned her fellowship in Hematology & Oncology Dana-Farber/Partners CancerCare. Her academic interests include Hodgkin/Non-Hodgkin lymphoma and the study of novel treatment agents. She is also ac...2020-01-3024 min
ACMS PodcastEpisode 10: Dr. Emily RuizEpisode 10 features ACMS member Emily Ruiz, MD, MPH, Director of High Risk-Skin Cancer Clinic, Dana-Farber/Brigham and Women's Cancer Center, Assistant Professor at Harvard Medical School. Dr. Ruiz discusses her article, Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma, published in the JAMA Dermatology in July of 2019.2019-09-2332 min
How We Treat: Colon and Rectal CancerEpisode #17: New Study on Role of Religion in TreatmentDr. Bleday dives into the findings of a recent study on role of organized religion in treatment with Professor Tyler VanderWeele. Dr. VanderWeele is the John L. Loeb and Frances Lehman Loeb Professor of Epidemiology at the Harvard School of Public Health.2019-09-1228 min
Understanding Cancer | Dana-Farber Cancer InstituteCancer Mythbusters: Colorectal CancerAs of 2019, colorectal cancer is the third most common cancer diagnosed in men and women in the United States — but survival after diagnosis has been gradually increasing in the past decade due to advances in treatment.
However, since 1994, cases of young-onset colorectal cancer have increased by 51 percent, according to the National Cancer Institute. In March 2019, Dana-Farber/Brigham and Women's Cancer Center announced the launch of the Young-Onset Colorectal Cancer Center, which focuses exclusively on the care of colorectal cancer patients under age 50, in an effort to address the alarming increase in rates among young adults.
In this episode of Cancer My...2019-08-2814 minHow We Treat: Colon and Rectal CancerEpisode #16: CRC in Young People with Dr Kimmie Ng - May 2019Bleday and Meyerhardt discuss a trend in colorectal cancer cases involving younger patients, and some resources available for patients at the cancer care center.2019-05-1016 min
Prostate Cancer and YouQuoc-Dien Trinh, MD -006Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Quoc-Dien Trinh, MD, assistant professor of surgery at Harvard Medical School and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center. On this podcast he discusses the gap in prostate cancer survival of African American men compared to Caucasian men. His data shows that the biological differences in tumor aggressiveness among African American men may have been exaggerated, and the gap in survival is more likely to be the result of racial inequity and lack of acc...2019-05-0112 minHow We Treat: Colon and Rectal CancerEpisode 15 - Rectal Cancer Imaging RevisitedWith Dr. Leslie Lee2019-04-0917 minHow We Treat: Colon and Rectal CancerEpisode #14: Supplements In Colon and Rectal Cancer - Feb. 2019 with Kimmie NgEpisode #14 with Kimmie Ng.2019-02-1522 min
Breastcancer.org PodcastSurgery Choice Seems to Affect Quality of Life for Younger WomenDr. Laura Dominici, surgeon at the Dana-Farber/Brigham and Women's Cancer Center, assistant professor of surgery at Harvard Medical School, and division chief of breast surgery at Brigham and Women's Faulkner Hospital, discusses the research she presented at the 2018 San Antonio Breast Cancer Symposium looking at how the type of breast cancer surgery affected quality of life in women 40 and younger who had been diagnosed with breast cancer. Listen to the podcast to hear Dr. Dominici explain:
the design of the study
what we can and can't infer from the results
why she hopes these results...2018-12-1310 minHow We Treat: Colon and Rectal CancerEpisode #13: Island Medicine On Bermuda - CRC PodcastDr. Ron Bleday speaks with two guests to discuss colorectal cancer care in the island setting of Bermuda. His guests include Dr. Chris Fosker and Dr. Boris Vestweber.2018-12-1216 min
WEEI/NESN Jimmy Fund Radio-TelethonOMF - Paul O’Mara, 68, myelofibrosis, Worcester with Dr. Joseph Antin, Chief and Program Director, Stem Cell Transplantation, Dana-Farber 8-22-18Paul, an avid jogger, began to get shortness of breath while working out. Soon after, he began to experience a full stomach shortly after starting to eat. After visiting his doctor, he was diagnosed with myelofibrosis.For his treatment, Paul has received a stem cell transplant and is now focusing on being reimmunized. He chose Dana-Farber for its world-class reputation for treating cancer.Paul’s experience at the Institute really took a turn in April 2017. He spent a month in the hospital and was then discharged to go home. He had to spend the...2018-08-2207 min
WEEI/NESN Jimmy Fund Radio-TelethonOMF - Brian Boyle, 33, chronic myeloid leukemia, Hingham with Dr. Richard Stone, director of the adult leukemia program, Dana-Farber 8-21-18Brian Boyle is a professional ice hockey player, currently playing for the New Jersey Devils. He is one of 13 children and grew up in Hingham. Brian attended St. Sebastian’s School, and then went on to play four years of ice hockey at Boston College. He was drafted to the Los Angeles Kings out of college.Brian’s professional hockey career was thrown off course when he was diagnosed with chronic myeloid leukemia in September 2017. He had no symptoms of cancer other than a “steady decline” in energy level. It wasn’t until a blood test, conducted in a team...2018-08-2211 min
JCO Oncology Practice PodcastWhat Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic EnvironmentDr. Pennell and co-authors Drs. Abel and Frosch discuss their editorial on public expectations in a shifting therapeutic environment. Read the related article. Support for JCO Oncology Practice podcasts is provided in part by AstraZeneca-- dedicated to advancing options and providing hope for people living with cancer. More information at AstraZeneca-us.com. Hello, and welcome back to the ASCO Journal of Oncology Practice podcast. This is Dr. Nate Pennell, medical oncologist at the Cleveland Clinic and consultant editor for the JOP. What do most people think today when they think about a cancer...2018-03-1213 min
Understanding Cancer | Dana-Farber Cancer InstituteCancer Mythbusters: Superfoods and CancerWhat should we eat, and what shouldn’t we eat? What keeps cancer patients healthy, and what can help fend off cancer in the first place? These are big questions, and it can be hard to tell the difference between a nutritional myth and a nutritional fact.
“Superfood,” a relatively new term, refers to foods that have certain supposed very good health benefits. In this episode, Stacy Kennedy, MPH, RD, a senior clinical nutritionist in Nutrition Services at Dana-Farber/Brigham and Women’s Cancer Center, helps us uncover what the real deal is with these foods — and whether they can help cancer2018-03-0111 min
How We Treat: Colon and Rectal CancerEpisode #12: Enhanced Recovery After Surgery (ERAS)Visit Howwetreat.org for full blog post.
Drs. Bleday & Meyerhardt speak with Dr. Kevin Elias about Enhanced Recovery After Surgery methods and studies taking place right now in reducing stress on the patient's body pre-surgery. Even eating, hydrating, and carbohydrates are involved in prepping for common surgeries CRC doctors will want to learn more about.2018-01-2326 min
AUAUniversityAUA CRPC Guidlines OverviewDr. Adam S. Kiebel presents a presentation on the 2017 AUA CRPC Guideline. Dr. Kibel is Chief of Urologic Surgery at both the Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, Massachusetts. In addition, he is Elliot Carr Cutler Professor of Surgery at Harvard University School of Medicine, Chairman of the Harvard Program in Urology Residency Program (Longwood) and Co-Leader of the Prostate Cancer Program for Dana Farber/Harvard Cancer Center. Dr Kibel received his undergraduate and medical degrees from Cornell University, completed his urology residency at the Harvard Urology Program, and his fellowship at the Brady Urologic In...2017-12-1436 minHow We Treat: Colon and Rectal CancerEpisode #11: Watch & Wait ProtocolEpisode #11: Watch & Wait Protocol by Dana-Farber/Brigham and Women’s Cancer Center2017-12-0528 minHow We Treat: Colon and Rectal CancerEpisode #10 - The IDEA Collaboration: 3-Months Versus 6-Months of Post Op ChemoDr. Bleday and Dr. Meyerhardt discuss the International Duration Evaluation of Adjuvant chemotherapy project (IDEA) with Dr. Axel Grothey from the Mayo Clinic. Interview was recorded at the 2017 ASCO Conference in Chicago.2017-07-2426 min
How We Treat: Colon and Rectal CancerEpisode #9: Heated Intraperitoneal Chemotherapy (HIPEC)This episode features discussion on Heated Intraperitoneal Chemotherapy (HIPEC) treatment. The experts joining the podcast to discuss this type of care are Dr. Nelya Melnitchouk and Dr. Tom Abrams from the GI team at the Dana Farber/Brigham and Women's Cancer Center in Boston.
HIPEC differs from other treatments because of the specific and targeted delivery method. The chemo does not circulate through the entire body during HIPEC. It only is directed at the cancerous cells in the abdomen area.2017-06-1130 min
How We Treat: Colon and Rectal CancerEpisode #8 - Treatment Of Early Anal Cancer In An HIV PatientEpisode #8 presents a case involving the treatment of an anal cancer patient that is also HIV positive. Dr. Harvey Mamon and Dr. Paul Sax discuss how this patient was successfully treated and the historical changes of how HIV cases have been treated in recent years.
Visit the episode library at www.howwetreat.org for more info.2017-04-2433 min
How We Treat: Colon and Rectal CancerEpisode #7 - Colorectal Cancer Clincal Trials [Pt. 2]In the second part of our discussion on today's colorectal cancer trials, Dr. James Fleshman joins Ron to discuss the ACOSOG Z6051 Randomized Clinical Trial. This surgical trial aims to decipher the differences of open versus laparoscopic surgery in the treatment of colorectal cancer.
In this episode, Jeff and Ron also answer a listener question and discuss the future of patient trials in this field.2017-03-2822 min
How We Treat: Colon and Rectal CancerEpisode #6 - Colorectal Cancer Clinical Trials [Pt. 1]The podcast's next two episodes will feature discussions around two recent and on-going clinical trials focused on patients with colon and rectal cancer. In episode #6, Dr. Deborah Schrag joins the podcast. She provides an inside look at the "Prospect" trial currently taking place.
Visit howwetreat.org for more information.2017-03-1124 min
How We Treat: Colon and Rectal CancerEpisode #5: Colorectal Cancer Genetics, Microsatellite Instability, and Checkpoint InhibitorsRon and Jeff discuss their care of a recent colorectal cancer patient with Lynch Syndrome. The episode explores the case's complications, immunotherapy, genetics, and steps in the treatment process when handling this type of case.
Visit www.howwetreat.org to learn more about our guests and contact us. Enjoy!2017-01-2924 min
How We Treat: Colon and Rectal CancerEpisode #4: Patient Frailty During Colorectal Cancer Care (December 2016)In episode 4, the hosts discuss the complications and processes that are involved in treating a frail colorectal cancer patient. Visit www.howwetreat.org to enhance your listening experience.2016-12-2130 min
WE Have CancerAdvances in Personalized and Precision Medicine, with Dr. Jeffrey Meyerhardt, M.D., MPHDr. Jeffrey Meyerhardt is the Clinical Director of the Gastrointestinal Cancer Center and Senior Physician at Dana-Farber Cancer Institute. In his research, Dr. Meyerhardt, who also is an Associate Professor of Medicine at Harvard Medical School and co-leader of the Center for Colon and Rectal Cancer at Dana-Farber/Brigham and Women’s Cancer Center, focuses primarily on […] The post Advances in Personalized and Precision Medicine, with Dr. Jeffrey Meyerhardt, M.D., MPH appeared first on The Colon Cancer Podcast.2016-11-1407 min
How We Treat: Colon and Rectal CancerEpisode #3: Colorectal Cancer and Inflammatory Bowel Disease (IBD)Dr. Bleday speaks with two of his colleagues about a case in which some complications arose with a colitis patient who developed upper rectal cancer.2016-11-1032 min
How We Treat: Colon and Rectal CancerEpisode #1: Post Operative Chemo [October 2016]Episode 01 (Post Operative Chemo): In the first ever episode of the podcast, the DFCI presents a discussion between our host Ronald Bleday and his colleague, Dr. Marios Giannakis. They discuss a real colorectal cancer case involving the use of chemotherapy after GI surgery and radiation.2016-10-1227 min